{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:42:29Z","timestamp":1785156149680,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Radiol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00256-023-04462-w","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T08:01:41Z","timestamp":1696406501000},"page":"995-1002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Phosphaturic mesenchymal tumor: two cases highlighting differences in clinical and radiologic presentation"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-2102","authenticated-orcid":false,"given":"Joey","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Most","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"4462_CR1","first-page":"468","volume-title":"WHO classification of tumours of soft tissue and bone","author":"CDM Fletcher","year":"2013","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, World Health O, International Agency for Research on C. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. p. 468. illustrations (chiefly color) p","edition":"4"},{"issue":"1","key":"4462_CR2","first-page":"33","volume":"16","author":"CR Mc","year":"1947","unstructured":"Mc CR. Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q J Med. 1947;16(1):33\u201346.","journal-title":"Q J Med"},{"issue":"7746","key":"4462_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0140-6736(72)92844-9","volume":"1","author":"DJ Evans","year":"1972","unstructured":"Evans DJ, Azzopardi JG. Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia. Lancet. 1972;1(7746):353\u20134.","journal-title":"Lancet"},{"issue":"1","key":"4462_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28(1):1\u201330.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4462_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00256-018-3014-5","volume":"48","author":"SM Broski","year":"2019","unstructured":"Broski SM, Folpe AL, Wenger DE. Imaging features of phosphaturic mesenchymal tumors. Skelet Radiol. 2019;48(1):119\u201327.","journal-title":"Skelet Radiol"},{"issue":"2","key":"4462_CR6","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.4158\/ACCR-2018-0300","volume":"5","author":"T Kaur","year":"2019","unstructured":"Kaur T, Rush ET, Bhattacharya RK. Phosphaturic Mesenchymal Heel Tumor Presenting with Tumor-Induced Osteomalacia. AACE Clin Case Rep. 2019;5(2):e138\u2013e41.","journal-title":"AACE Clin Case Rep"},{"issue":"6","key":"4462_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3174\/ajnr.A7513","volume":"43","author":"JC Benson","year":"2022","unstructured":"Benson JC, Trejo-Lopez JA, Nassiri AM, Eschbacher K, Link MJ, Driscoll CL, et al. Phosphaturic Mesenchymal Tumor. AJNR Am J Neuroradiol. 2022;43(6):817\u201322.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"4462_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.revmed.2016.08.020","volume":"38","author":"T Chazal","year":"2017","unstructured":"Chazal T, Khanine V, Lidove O, Godot S, Ziza JM. Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor. Rev Med Interne. 2017;38(6):412\u20135.","journal-title":"Rev Med Interne"},{"issue":"1","key":"4462_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1186\/s12891-021-04558-1","volume":"22","author":"H Qin","year":"2021","unstructured":"Qin H, Zeng H, Li H, Yuan S, Yang J. Malignant phosphaturic mesenchymal tumor-ossifying fibroma-like subtype: a case report and literature review. BMC Musculoskelet Disord. 2021;22(1):677.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4462_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","volume":"108","author":"P Florenzano","year":"2021","unstructured":"Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor-Induced Osteomalacia. Calcif Tissue Int. 2021;108(1):128\u201342.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"4462_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004;19(3):429\u201335.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"4462_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"The HYP Consortium","year":"1995","unstructured":"The HYP Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet. 1995;11(2):130\u20136.","journal-title":"Nat Genet"},{"issue":"3","key":"4462_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"Consortium A","year":"2000","unstructured":"Consortium A. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26(3):345\u20138.","journal-title":"Nat Genet"},{"issue":"5","key":"4462_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112(5):683\u201392.","journal-title":"J Clin Invest"},{"issue":"2","key":"4462_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/ddt429","volume":"23","author":"YH Lim","year":"2014","unstructured":"Lim YH, Ovejero D, Sugarman JS, Deklotz CM, Maruri A, Eichenfield LF, et al. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet. 2014;23(2):397\u2013407.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"4462_CR16","doi-asserted-by":"publisher","first-page":"e19090","DOI":"10.1097\/MD.0000000000019090","volume":"99","author":"D Li","year":"2020","unstructured":"Li D, Zhu R, Zhou L, Zhong D. Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors. Medicine (Baltimore). 2020;99(7):e19090.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4462_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12891-017-1756-1","volume":"18","author":"QY Zuo","year":"2017","unstructured":"Zuo QY, Wang H, Li W, Niu XH, Huang YH, Chen J, et al. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients. BMC Musculoskelet Disord. 2017;18(1):403.","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"4462_CR18","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","volume":"471","author":"CK Ledford","year":"2013","unstructured":"Ledford CK, Zelenski NA, Cardona DM, Brigman BE, Eward WC. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed? Clin Orthop Relat Res. 2013;471(11):3618\u201325.","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"4462_CR19","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s11547-021-01412-1","volume":"126","author":"MAM Hussein","year":"2021","unstructured":"Hussein MAM, Cafarelli FP, Paparella MT, Rennie WJ, Guglielmi G. Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway. Radiol Med. 2021;126(12):1609\u201318.","journal-title":"Radiol Med"},{"issue":"2","key":"4462_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s43465-019-00005-5","volume":"54","author":"AS Kawthalkar","year":"2020","unstructured":"Kawthalkar AS, Janu AK, Deshpande MS, Gala KB, Gulia A, Puri A. Phosphaturic Mesenchymal Tumors from Head to Toe: Imaging Findings and Role of the Radiologist in Diagnosing Tumor-Induced Osteomalacia. Indian J Orthop. 2020;54(2):215\u201323.","journal-title":"Indian J Orthop"},{"issue":"5","key":"4462_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jbspin.2018.01.004","volume":"85","author":"F Busquet","year":"2018","unstructured":"Busquet F, Gahier-Penhoat M, Lescour V, Maugars Y, Guillot P. Contribution of ultrasound to diagnosing a phosphaturic mesenchymal tumor. Joint Bone Spine. 2018;85(5):639\u201340.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"4462_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cen.12426","volume":"81","author":"S Jadhav","year":"2014","unstructured":"Jadhav S, Kasaliwal R, Lele V, Rangarajan V, Chandra P, Shah H, et al. Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET\/CT vs somatostatin receptor-based functional scans: a series of nine patients. Clin Endocrinol. 2014;81(1):31\u20137.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"4462_CR23","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","volume":"40","author":"K Agrawal","year":"2015","unstructured":"Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, et al. Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med. 2015;40(1):e6\u2013e10.","journal-title":"Clin Nucl Med"},{"issue":"26","key":"4462_CR24","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa010839","volume":"345","author":"J Seufert","year":"2001","unstructured":"Seufert J, Ebert K, Muller J, Eulert J, Hendrich C, Werner E, et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med. 2001;345(26):1883\u20138.","journal-title":"N Engl J Med"},{"issue":"1072","key":"4462_CR25","doi-asserted-by":"publisher","first-page":"20160811","DOI":"10.1259\/bjr.20160811","volume":"90","author":"D Singh","year":"2017","unstructured":"Singh D, Chopra A, Ravina M, Kongara S, Bhatia E, Kumar N, et al. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET\/CT scan in identifying the culprit lesion and its management. Br J Radiol. 2017;90(1072):20160811.","journal-title":"Br J Radiol"},{"issue":"9","key":"4462_CR26","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1097\/PAS.0b013e3181aa2311","volume":"33","author":"A Bahrami","year":"2009","unstructured":"Bahrami A, Weiss SW, Montgomery E, Horvai AE, Jin L, Inwards CY, et al. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia. Am J Surg Pathol. 2009;33(9):1348\u201354.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"4462_CR27","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","volume":"59","author":"N Weidner","year":"1987","unstructured":"Weidner N, Santa CD. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59(8):1442\u201354.","journal-title":"Cancer"},{"issue":"24","key":"4462_CR28","doi-asserted-by":"publisher","first-page":"10997","DOI":"10.7314\/APJCP.2014.15.24.10997","volume":"15","author":"A Ulas","year":"2014","unstructured":"Ulas A, Dede DS, Sendur MA, Akinci MB, Yalcin B. Expectations of response from octreotide therapy in recurrent phosphaturic mesenchymal tumors--do they reflect reality? Asian Pac J Cancer Prev. 2014;15(24):10997\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"4462_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2967\/jnmt.116.177873","volume":"44","author":"S Basu","year":"2016","unstructured":"Basu S, Fargose P. 177Lu-DOTATATE PRRT in Recurrent Skull-Base Phosphaturic Mesenchymal Tumor Causing Osteomalacia: A Potential Application of PRRT Beyond Neuroendocrine Tumors. J Nucl Med Technol. 2016;44(4):248\u201350.","journal-title":"J Nucl Med Technol"},{"issue":"5","key":"4462_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jos.2020.07.006","volume":"26","author":"H Kobayashi","year":"2021","unstructured":"Kobayashi H, Makise N, Ito N, Koga M, Zhang L, Ishibashi Y, et al. Surgical margin for phosphaturic mesenchymal tumors in soft tissues: An analysis of the radiological histopathological correlation. J Orthop Sci. 2021;26(5):870\u20137.","journal-title":"J Orthop Sci"},{"issue":"3","key":"4462_CR31","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18(3):R53\u201377.","journal-title":"Endocr Relat Cancer"}],"container-title":["Skeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-023-04462-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00256-023-04462-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-023-04462-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T08:05:11Z","timestamp":1711526711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00256-023-04462-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["4462"],"URL":"https:\/\/doi.org\/10.1007\/s00256-023-04462-w","relation":{},"ISSN":["0364-2348","1432-2161"],"issn-type":[{"value":"0364-2348","type":"print"},{"value":"1432-2161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"6 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from both subjects described in this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}